SeaStar Medical Projects Multibillion-Dollar Market Potential for its Selective Cytopheretic Device in Initial Target Indications
December 11, 2024 06:30 ET
|
SeaStar Medical Holding Corporation
U.S. total addressable market for five initial indications is $25 to $33 billion REMINDER: Business Update Conference Call begins at 4:30 p.m. Eastern time today DENVER , Dec. 11, 2024 (GLOBE...
SeaStar Medical to Hold Business Update Conference Call on December 11, 2024
December 04, 2024 08:30 ET
|
SeaStar Medical Holding Corporation
DENVER, Dec. 04, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of...
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Support SeaStar Medical’s Proposals to Ratify the Issuance of Shares and to Reduce the Number of Authorized Shares
November 22, 2024 08:30 ET
|
SeaStar Medical Holding Corporation
SeaStar Medical urges stockholders to vote FOR all proxy proposals prior to the Special Meeting of Stockholders to be held November 26, 2024 DENVER, Nov. 22, 2024 (GLOBE NEWSWIRE) -- SeaStar...
ICU DEADLINE: ROSEN, TOP RANKED NATIONAL INVESTOR ATTORNEYS, Encourages SeaStar Medical Holding Corporation Investors to Secure Counsel Before Important September 6 Deadline in Securities Class Action – ICU
September 03, 2024 12:40 ET
|
The Rosen Law Firm PA
NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of SeaStar Medical Holding Corporation (NASDAQ: ICU, ICUCW)...
ICU DEADLINE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages SeaStar Medical Holding Corporation Investors to Secure Counsel Before Important September 6 Deadline in Securities Class Action – ICU
August 30, 2024 16:40 ET
|
The Rosen Law Firm PA
NEW YORK, Aug. 30, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of SeaStar Medical Holding Corporation (NASDAQ: ICU, ICUCW)...
ICU DEADLINE NOTICE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages SeaStar Medical Holding Corporation Investors to Secure Counsel Before Important September 6 Deadline in Securities Class Action – ICU
August 26, 2024 17:11 ET
|
The Rosen Law Firm PA
NEW YORK, Aug. 26, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of SeaStar Medical Holding Corporation (NASDAQ: ICU, ICUCW)...
SeaStar Medical Provides Updates on Enrollment of Adult Pivotal Clinical Study and Commercial Launch of Quelimmune, FDA-Approved in Pediatric Patients
March 12, 2024 08:30 ET
|
SeaStar Medical Holding Corporation
Company plans to hold a business update conference call in April DENVER, March 12, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial stage medical device...
FDA Grants SeaStar Medical’s Selective Cytopheretic Device Breakthrough Device Designation for Hepatorenal Syndrome
October 18, 2023 08:30 ET
|
SeaStar Medical Holding Corporation
DENVER, Oct. 18, 2023 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a medical device company developing proprietary solutions to reduce the consequences of hyperinflammation...
SeaStar Medical to Present at the Dawson James Small Cap Growth Conference on October 12, 2023
October 05, 2023 08:30 ET
|
SeaStar Medical Holding Corporation
DENVER, Oct. 05, 2023 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a medical device company developing proprietary solutions to reduce the consequences of hyperinflammation...
SeaStar Medical Reports First Quarter 2023 Financial Results and Provides a Business Update
May 15, 2023 16:45 ET
|
SeaStar Medical Holding Corporation
DENVER, May 15, 2023 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU) (“SeaStar Medical” or the “Company”), a medical device company developing proprietary solutions to reduce...